Intec Pharma
Nir Sassi is the current Chief Financial Officer at Intec Pharma. Nir has held this position since 2010. Prior to joining Intec Pharma, Nir worked as a Senior Manager at PwC. Nir's experience at PwC includes two years relocation to PwC New York office.
Nir Sassi completed a Bachelor of Arts in accounting and economics at Ben-Gurion University of the Negev.
Nir Sassi reports to Jeffrey A. Meckler , Vice Chairman & CEO . They are on a team with Walt A. Linscott - Chief Business Officer, R. Michael Gendreau - Chief Medical Officer, and Nadav Navon - Chief Operating Officer.
This person is not in any offices
Intec Pharma
Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel ga...